Loading...
XNAS
NUTX
Market cap958mUSD
Dec 05, Last price  
160.95USD
1D
2.65%
1Q
93.03%
IPO
-59.76%
Name

Nutex Health Inc

Chart & Performance

D1W1MN
XNAS:NUTX chart
P/E
18.37
P/S
2.00
EPS
8.76
Div Yield, %
Shrs. gr., 5y
-34.22%
Rev. gr., 5y
37.67%
Revenues
480m
+93.80%
220,4691,266,3602,548,6530053,64791,37397,057,120273,422,221331,531,311219,294,306247,646,316479,948,633
Net income
52m
P
605,288158,137-383,39383,809-7,432,241582,062-2,814,24516,483,467105,969,885132,593,328-432,739,618-45,786,61452,179,168
CFO
23m
+1,742.79%
0-889,104-664,57444,907-274,223-714,623-480,04912,124,66481,264,270173,432,48650,607,1081,256,45223,153,807

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
IPO date
Mar 18, 2011
Employees
800
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT